Femme et Homme
- | Pays :
- Finland
- Canada
- United States
- ...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to measure how active BMS-936558 (nivolumab) is against Renal Cell Carcinoma (RCC) as measured by the disease not progressing and whether a dose response relationship exists.
Critère d'inclusion
- Renal Cell Carcinoma